STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue
+8.79%
EPS
+12.8%
Free cash flow
+43.6%
Total debt
−0.21%

Quarter to September 2026, against a year earlier

252.70 1.42 −0.56%
Market cap
$24.8B
P/E
30.0×
Fwd P/E
25.1×
Dividend yield
1.02%
F-score
9/9
Altman Z
5.10
Beneish M
−2.68
Dividend safety
86/100
Sep '26 From the 10-Q filed 5 Nov Jun '26 Mar '26 Dec '25 Older periods
P/E ratio
24.82 25.65 27.78 35.26

+8 more quarters

P/S ratio
3.31 3.40 3.66 4.27
P/FCF ratio
21.80 21.96 22.09 26.58
P/Operating CF
70.71 55.98 64.74 83.49
P/B ratio
2.81 2.85 3.02 3.47
EV/Sales
3.54 3.64 3.91 4.55
EV/EBITDA
13.09 13.45 14.61 17.82
EV/FCF
23.26 23.46 23.61 28.29
Current Ratio
2.05 1.91 2.09 2.48
Net Debt/EBITDA
3.24 3.44 3.39 3.73
Debt/Equity
0.26 0.26 0.27 0.26
Earnings Yield
4.03% 3.90% 3.60% 2.84%
Free Cash Flow Yield
4.59% 4.55% 4.53% 3.76%
Free Cash Flow per Share
2.97 2.86 2.50 2.14
Book value per Share
74.73 73.99 73.29 72.99
Free Cash Flow
289.00 279.60 245.30 209.90
EV/EBIT
18.63 19.24 21.06 26.46
Other line items

Show all line items

Columns are period end dates · fundamentals updated 5 Nov 2026